Condition: Effect of Drug · Urinary Bladder, Overactive · Sponsor: Mackay Memorial Hospital
To investigates the effects of solifenacin or mirabegron with local estrogen versus combination treatment with solifenacin and mirabegron in women with overactive bladder
This description comes directly from the study's public registry record.
Hui-Hsuan Lau, MD · +886-2-25433535 · huihsuan1220@gmail.com
Always discuss trial participation with your own doctor first.
| Mackay Memorial Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06479720